Loading...
XSTO
PLUN
Market cap2mUSD
, Last price  
SEK
Name

ProstaLund AB

Chart & Performance

D1W1MN
XSTO:PLUN chart
No data to show
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
39.17%
Rev. gr., 5y
1.27%
Revenues
14m
-38.19%
7,654,0008,614,0009,613,00013,613,00014,612,00013,544,00013,567,00012,886,00012,465,00017,073,00017,411,00022,206,00013,725,000
Net income
-23m
L+33.05%
-561,000-4,645,000-7,786,000-9,373,000-11,974,000-16,894,000-12,950,000-10,728,000-10,041,000-7,919,000-11,303,000-17,010,000-22,631,000
CFO
-23m
L-5.08%
-2,605,000-3,875,000-10,834,000-9,750,000-14,407,000-16,114,000-11,893,000-9,115,000-8,581,000-5,804,000-16,202,000-23,801,000-22,591,000

Profile

ProstaLund AB (publ) develops and sells urological devices for the treatment of patients with benign prostatic hyperplasia (BPH) in Sweden and internationally. The company also offers CoreTherm, a heat treatment of BPH; and Gepan instill for the treatment of chronic bladder inflammation. Its products are used in hospitals and clinics. The company was founded in 1991 and is based in Lund, Sweden. ProstaLund AB (publ) is a subsidiary of Farstorps Gard Forvaltnings AB.
URL
https://www.prostalund.se/
IPO date
Oct 24, 2013
Employees
10
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
13,725
-38.19%
22,206
27.54%
17,411
1.98%
Cost of revenue
36,552
38,778
28,339
Unusual Expense (Income)
NOPBT
(22,827)
(16,572)
(10,928)
NOPBT Margin
Operating Taxes
205
Tax Rate
NOPAT
(22,827)
(16,572)
(11,133)
Net income
(22,631)
33.05%
(17,010)
50.49%
(11,303)
42.73%
Dividends
Dividend yield
Proceeds from repurchase of equity
26,952
33,942
19,837
BB yield
-2.74%
-30.42%
-9.11%
Debt
Debt current
400
400
400
Long-term debt
533
933
1,333
Deferred revenue
Other long-term liabilities
(1,333)
Net debt
(6,889)
(14,017)
(10,542)
Cash flow
Cash from operating activities
(22,591)
(23,801)
(16,202)
CAPEX
(6,989)
(146)
(4,754)
Cash from investing activities
(6,989)
(3,345)
(4,754)
Cash from financing activities
22,372
30,221
19,992
FCF
(23,504)
(25,020)
(13,925)
Balance
Cash
7,822
15,350
12,275
Long term investments
Excess cash
7,136
14,240
11,404
Stockholders' equity
(114,221)
(51,635)
Invested Capital
56,114
170,845
95,029
ROIC
ROCE
EV
Common stock shares outstanding
130,346
68,447
54,486
Price
7.54
362.58%
1.63
-59.20%
4.00
-3.50%
Market cap
982,809
780.91%
111,568
-48.74%
217,670
9.62%
EV
975,920
97,551
311,992
EBITDA
(22,827)
(16,307)
(10,707)
EV/EBITDA
Interest
177
173
207
Interest/NOPBT